Familial lipodystrophy associated with neurodegeneration and congenital cataracts

被引:12
作者
Berger, JR [1 ]
Oral, EA
Taylor, SL
机构
[1] Univ Kentucky, Dept Neurol, Kentucky Clin L445, Coll Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Internal Med, Coll Med, Lexington, KY 40536 USA
[3] NIDDKD, NIH, Diabet Branch, Bethesda, MD 20892 USA
关键词
D O I
10.1212/WNL.58.1.43
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The lipodystrophies are characterized by loss of body fat and metabolic disturbances, but the CNS is seldom affected. Methods: An investigation of a family with partial lipodystrophy and neurologic abnormalities included lipid analysis, dual-energy x-ray absorbtiometry (DEXA) for adiposity, insulin resistance, karyotype and other genetic analyses, peroxisomal function, glycosylation pattern of transferrin and thyroglobulin, and muscle biopsy. Results: The propositus, a 28-year-old woman with congenital partial lipodystrophy and cataracts, presented with a spastic-ataxic gait and lower extremity paresthesiae at age 18. Laboratory investigation revealed a type V hyperlipidemia pattern, insulin resistance, and high alpha-tocopherol levels. A similar syndrome in other family members suggested an autosomal dominant pattern of inheritance. Discussion: The progressive neurologic degenerative condition associated with this autosomal dominant, partial lipodystrophy may be misdiagnosed as MS or spinocerebellar degeneration. Search for a few relevant candidate genes was unrevealing. A genome-wide search to determine the molecular etiology can be undertaken if other similar cases are identified.
引用
收藏
页码:43 / 47
页数:5
相关论文
共 27 条
[1]   PARTIAL (LOCALIZED) LIPODYSTROPHY - REPORT OF A CASE WITH MUSCLE AND SKIN ABNORMALITIES [J].
AFIFI, AK ;
BERGMAN, RA ;
ZAYNOUN, ST ;
BAHUTH, NB ;
KRAYDIEH, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1985, 12 (01) :198-203
[2]  
Anderson JL, 1999, AM J MED GENET, V82, P161, DOI 10.1002/(SICI)1096-8628(19990115)82:2<161::AID-AJMG12>3.0.CO
[3]  
2-0
[4]   Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes [J].
Arioglu, E ;
Duncan-Morin, J ;
Sebring, N ;
Rother, KI ;
Gottlieb, N ;
Lieberman, J ;
Herion, D ;
Kleiner, DE ;
Reynolds, J ;
Premkumar, A ;
Sumner, AE ;
Hoofnagle, J ;
Reitman, ML ;
Taylor, SI .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :263-274
[5]  
BERGE T, 1976, ACTA PATH MICRO IM A, V84, P47
[6]  
Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO
[7]  
2-J
[8]  
FOSTER DW, 1994, HARRISONS PRINCIPLES, P2132
[9]   A gene for congenital generalized lipodystrophy maps to human chromosome 9q34 [J].
Garg, A ;
Wilson, R ;
Barnes, R ;
Arioglu, E ;
Zaidi, Z ;
Gurakan, F ;
Kocak, N ;
O'Rahilly, S ;
Taylor, SI ;
Patel, SB ;
Bowcock, AM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) :3390-3394
[10]   Congenital Disorders of Glycosylation (CDG):: A rapidly expanding group of neurometabolic disorders [J].
Grünewald, S ;
Matthijs, G .
NEUROPEDIATRICS, 2000, 31 (02) :57-59